Cargando…
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
We describe our institutional experience of developing a liquid biopsy approach using circulating tumor DNA (ctDNA) analysis for personalized medicine in cancer patients, focusing on the hurdles encountered during the multistep process in order to benefit other investigators wishing to set up this t...
Autores principales: | Chen, Michelle, Jian, Damon, Sidorov, Maxim, Woo, Rinette W. L., Kim, Angela, Stone, David E., Nazarian, Ari, Nosrati, Mehdi, Ice, Ryan J., de Semir, David, Dar, Altaf A., Luštrik, Roman, Kokošar, Janez, Ausec, Luka, Rowbotham, Michael C., Tranah, Gregory J., Kashani-Sabet, Mohammed, Soroceanu, Liliana, McAllister, Sean D., Desprez, Pierre-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692455/ https://www.ncbi.nlm.nih.gov/pubmed/36579573 http://dx.doi.org/10.3390/jpm12111845 |
Ejemplares similares
-
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies
por: Ice, Ryan J., et al.
Publicado: (2019) -
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
por: Sidorov, Maxim, et al.
Publicado: (2023) -
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020) -
Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress
por: Bezrookove, Vladimir, et al.
Publicado: (2021) -
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma
por: Ursu, Sarah, et al.
Publicado: (2019)